The Food and Drug Administration (FDA) Opioid Policy Steering Committee is holding a public hearing on January 30, 2018.

    The purpose of the hearing, entitled, “Opioid Policy Steering Committee: Prescribing Intervention—Exploring a Strategy for Implementation,” hearing is to gain stakeholder input on “how the FDA might, under its Risk Evaluation and Mitigation Strategy (REMS) authority, improve the safe use of opioid analgesics by curbing overprescribing to decrease the occurrence of new addictions and limit misuse and abuse of opioid analgesics.” 

    Public comments will also be accepted after the public hearing until March 16, 2018.


For problems with the site please contact us at